Cilostazol After Lower Extremity Arterial Revascularization Trial

Clinical trial NCT02374957 · TERMINATED

Trial details

NCT number: NCT02374957
Sponsor: Wake Forest University Health Sciences
Status: TERMINATED
Phase: Phase 4
Study type: INTERVENTIONAL

Peripheral Arterial Disease Claudication (Finding)

Start date: 2015-02-01
Primary completion: 2017-06-30
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.